Medical technology company Masimo has been facing off with Apple in court since 2020, and while Masimo has scored some wins, ...

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's ...

Medical tech company Masimo (NASDAQ:MASI) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up ...

Second Quarter 2025 Results Key Financial Results Revenue: US$370.9m (down 25% from 2Q ...

Masimo (Nasdaq: MASI) shares dipped after hours today on second-quarter results that came in ahead of the consensus forecast.

Medical tech company Masimo (NASDAQ:MASI) will be reporting earnings this Tuesday afternoon. Here’s what investors should ...

Masimo ( ($MASI) ) has shared an update. On August 5, 2025, Masimo Corporation announced its financial results for the second quarter of 2025, ...

Apple removed blood oxygen monitoring from the Apple Watch in early 2024. Somebody has to blink for it to return, and it ...

Discover insights from Masimo Corporation's Q2 2025 earnings call. Growth strategies, tariff mitigation, and EPS updates highlight a confident outlook.

New York-based law firm Kasowitz LLP today announced that it is filing a lawsuit against Apple on behalf of its client, Texas ...

Masimo's second-quarter 2025 performance beats earnings and revenue estimates, expands margins and lifts 2025 outlook.

Apple's removal of the blood oxygen monitoring feature from its watch in 2024 shows no signs of reversal, despite its ...